Search research articles
Contact Us
Filters
Showing results (81-90 of 167) with videos related to
Page
of 17
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam
|
March 28, 2013
Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model
Hemant Kumar, In-Su Kim, Sandeep Vasant More, et al.
Aging and Disease
|
December 10, 2024
Gut Microbiota-Immune System Interactions in Health and Neurodegenerative Diseases: Insights into Molecular Mechanisms and Therapeutic Applications
Rengasamy Balakrishnan, Shin-Il Kang, Ji-Yeon Lee, et al.
Journal of Neurochemistry
|
April 9, 2005
Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei, Khatuna Kipiani, Susanne Petri, et al.
Journal of Pharmacological Sciences
|
February 6, 2010
MMHD [(S,E)-2-methyl-1-(2-methylthiazol-4-yl) hexa-1,5-dien-ol], a novel synthetic compound derived from epothilone, suppresses nuclear factor-kappaB-mediated cytokine expression in lipopolysaccharide-stimulated BV-2 microglia
Na-Ra Jeon, Sushruta Koppula, Byung-Wook Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 12, 2022
Synthesis of 1-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-2-morpholinoethane-1,2-dione analogues and their inhibitory activities with reduced cytotoxicity in lipopolysaccharide-induced BV2 cells
Sung-Hwa Yoon, Duk-Yeon Cho, Jun-Hyuk Han, et al.
Molecules and Cells
|
March 6, 2008
Contribution of TLR2 to the initiation of ganglioside-triggered inflammatory signaling
Hee Jung Yoon, Sae Bom Jeon, Kyoungho Suk, et al.
Neurochemistry International
|
February 19, 2025
The novel peptide DBCH reduces LPS-stimulated NF-κB/MAPK signaling in BV-2 microglia and ameliorates cognitive impairment in scopolamine-treated mice by modulating BDNF/CREB
Ye-Ji Yu, Mujeeb Ur Rahman, Rengasamy Balakrishnan, et al.
Neuropharmacology
|
December 31, 2019
2-(5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-N-(2-hydroxyethyl)-2-oxoacetamide (CDMPO) has anti-inflammatory properties in microglial cells and prevents neuronal and behavioral deficits in MPTP mouse model of Parkinson's disease
Byungwook Kim, Ju-Young Park, Duk-Yeon Cho, et al.
Neurotoxicology
|
January 28, 2012
Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium
Meihua Jin, Byung Wook Kim, Sushruta Koppula, et al.
Biological & Pharmaceutical Bulletin
|
December 1, 2012
Simultaneous measurement of serotonin, dopamine and their metabolites in mouse brain extracts by high-performance liquid chromatography with mass spectrometry following derivatization with ethyl chloroformate
Ju-Young Park, Seung-Woon Myung, In-Soo Kim, et al.
Page
of 17
Search research articles
Search
Showing results (81-90 of 167) with videos related to
Sort By:
Page
of 17
Evidence-Based Complementary and Alternative Medicine : Ecam
|
March 28, 2013
Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model
Hemant Kumar, In-Su Kim, Sandeep Vasant More, et al.
Aging and Disease
|
December 10, 2024
Gut Microbiota-Immune System Interactions in Health and Neurodegenerative Diseases: Insights into Molecular Mechanisms and Therapeutic Applications
Rengasamy Balakrishnan, Shin-Il Kang, Ji-Yeon Lee, et al.
Journal of Neurochemistry
|
April 9, 2005
Integrative role of cPLA with COX-2 and the effect of non-steriodal anti-inflammatory drugs in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei, Khatuna Kipiani, Susanne Petri, et al.
Journal of Pharmacological Sciences
|
February 6, 2010
MMHD [(S,E)-2-methyl-1-(2-methylthiazol-4-yl) hexa-1,5-dien-ol], a novel synthetic compound derived from epothilone, suppresses nuclear factor-kappaB-mediated cytokine expression in lipopolysaccharide-stimulated BV-2 microglia
Na-Ra Jeon, Sushruta Koppula, Byung-Wook Kim, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 12, 2022
Synthesis of 1-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-2-morpholinoethane-1,2-dione analogues and their inhibitory activities with reduced cytotoxicity in lipopolysaccharide-induced BV2 cells
Sung-Hwa Yoon, Duk-Yeon Cho, Jun-Hyuk Han, et al.
Molecules and Cells
|
March 6, 2008
Contribution of TLR2 to the initiation of ganglioside-triggered inflammatory signaling
Hee Jung Yoon, Sae Bom Jeon, Kyoungho Suk, et al.
Neurochemistry International
|
February 19, 2025
The novel peptide DBCH reduces LPS-stimulated NF-κB/MAPK signaling in BV-2 microglia and ameliorates cognitive impairment in scopolamine-treated mice by modulating BDNF/CREB
Ye-Ji Yu, Mujeeb Ur Rahman, Rengasamy Balakrishnan, et al.
Neuropharmacology
|
December 31, 2019
2-(5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-N-(2-hydroxyethyl)-2-oxoacetamide (CDMPO) has anti-inflammatory properties in microglial cells and prevents neuronal and behavioral deficits in MPTP mouse model of Parkinson's disease
Byungwook Kim, Ju-Young Park, Duk-Yeon Cho, et al.
Neurotoxicology
|
January 28, 2012
Molecular effects of activated BV-2 microglia by mitochondrial toxin 1-methyl-4-phenylpyridinium
Meihua Jin, Byung Wook Kim, Sushruta Koppula, et al.
Biological & Pharmaceutical Bulletin
|
December 1, 2012
Simultaneous measurement of serotonin, dopamine and their metabolites in mouse brain extracts by high-performance liquid chromatography with mass spectrometry following derivatization with ethyl chloroformate
Ju-Young Park, Seung-Woon Myung, In-Soo Kim, et al.
Page
of 17